Practitioners who specialize in urology, who are male, who seldom order PSA tests, and who are affiliated with specific hospitals are more likely than are other medical practitioners to inappropriately order a PSA test for asymptomatic patients over age 75 years or under age 40, according to a study from the Massachusetts Veterans Epidemiology Research and Information Center.
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.